Clinical Trials Directory

Trials / Completed

CompletedNCT00512226

Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia

Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't develope significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpouse of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and cardiac T2\*MRI in order to determine the cardiac and liver iron.

Conditions

Interventions

TypeNameDescription
OTHERCardiac and Liver T2* MRILaboratory examinations that are routinely used in follow up of those patients and T2\* MRI analysis.

Timeline

Start date
2007-09-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2007-08-07
Last updated
2011-08-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00512226. Inclusion in this directory is not an endorsement.